Medipost Co (XKRX:078160) Cash Flow from Discontinued Operations : ₩0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Medipost Co's cash flow from discontinued operations for the three months ended in Dec. 2023 was ₩0 Mil. It means Medipost Co received ₩0 Mil from the sale of part of business quarterly. Medipost Co's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0 Mil.

Medipost Co Cash Flow from Discontinued Operations Historical Data

The historical data trend for Medipost Co's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Cash Flow from Discontinued Operations Chart

Medipost Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

Medipost Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

Medipost Co Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

Medipost Co Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Medipost Co's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (XKRX:078160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines